Abstract
Our understanding of the B-cell subsets found in human blood and their functional significance has advanced greatly in the past decade. This has been aided by the evolution of high dimensional phenotypic tools such as mass cytometry and single-cell RNA sequencing which have revealed heterogeneity in populations that were previously considered homogenous. Despite this, there is still uncertainty and variation between studies as to how B-cell subsets are identified and named. This review will focus on the most commonly encountered subsets of B cells in human blood and will describe gating strategies for their identification by flow and mass cytometry. Important changes to population frequencies and function in common inflammatory and autoimmune diseases will also be described.
| Original language | English |
|---|---|
| Pages (from-to) | 201-216 |
| Number of pages | 16 |
| Journal | Clinical and Experimental Immunology |
| Volume | 210 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Dec 2022 |
Keywords
- autoimmunity
- B cell
- immune checkpoints
- systemic lupus erythematosus
